Zonghai Li

5PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 30, 2026
Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in patients with Advanced Hepatocellular Carcinoma.

|Jun 11, 2026
A novel triple-knockout allogeneic BCMA CAR T cell therapy (CT0590) in multiple myeloma: preclinical and phase I study.

|Dec 08, 2025
In-depth plasma proteomics reveals the dynamic changes and prognostic biomarkers for chimeric antigen receptor-glypican-3 T-cell therapy in patients with hepatocellular carcinoma.

Xudong Zhu, Ziliang Yang, Bin Li

|May 31, 2019
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma.

Ying Liu, Shengmeng Di, Bizhi Shi

|Sep 21, 2017
Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells.

Hua Jiang, Bo Song, Peng Wang

Pageof 1

Frequent Collaborators

2 joint publications

Hua Jiang

1 joint publications

Tingbo Liang

1 joint publications

Xuqi Sun

1 joint publications

Wanwan Gao